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Abstract
Background: Theory of mind (ToM) refers to the ability to attribute mental states, thoughts (cognitive component)
or feelings (affective component) to others. This function has been studied in many neurodegenerative diseases;
however, to our knowledge, no studies investigating ToM in dementia with Lewy bodies (DLB) have been
published. The aim of our study was to assess ToM in patients with DLB and to search for neural correlates of
potential deficits.
Methods: Thirty-three patients with DLB (DLB group) and 15 patients with Alzheimer’s disease (AD group), all in
the early stage of the disease, as well as 16 healthy elderly control subjects (HC group), were included in the study.
After a global cognitive assessment, we used the Faux Pas Recognition (FPR) test, the Reading the Mind in the
Eyes (RME) test and Ekman’s Facial Emotion Recognition test to assess cognitive and affective components of ToM.
Patients underwent cerebral 3-T magnetic resonance imaging, and atrophy of grey matter was analysed using
voxel-based morphometry. We performed a one-sample t test to investigate the correlation between each ToM
score and grey matter volume and a two-sample t test to compare patients with DLB impaired with those
non-impaired for each test.
Results: The DLB group performed significantly worse than the HC group on the FPR test (P = 0.033) and
the RME test (P = 0.015). There was no significant difference between the AD group and the HC group or
between the DLB group and the AD group. Some brain regions were associated with ToM impairments. The
prefrontal cortex, with the inferior frontal cortex and the orbitofrontal cortex, was the main region, but we
also found correlations with the temporoparietal junction, the precuneus, the fusiform gyrus and the insula.
Conclusions: This study is the first one to show early impairments of ToM in DLB. The two cognitive and
affective components both appear to be affected in this disease. Among patients with ToM difficulties, we
found atrophy in brain regions classically involved in ToM, which reinforces the neuronal network of ToM.
Further studies are now needed to better understand the neural basis of such impairment.
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Background
Theory of mind (ToM) refers to the capacity to under-
stand someone else’s emotions and mental state. ToM
can be separated into two systems: the affective and cog-
nitive components. The affective ToM is involved in
drawing inferences about other people’s emotions and
feelings; the cognitive ToM is involved in drawing infer-
ences about other people’s beliefs and intentions [1]. Re-
searchers have developed experimental tests to assess
this capacity. The main tests used in the literature are
the first- and second-order false belief tasks, the Faux
Pas Recognition (FPR) test, the Reading the Mind in the
Eyes (RME) test and Ekman’s Facial Emotion Recogni-
tion test [2]. Neuroimaging and lesion studies have tried
to establish the neural correlates of ToM. In their review
of the literature, Carrington and Bailey [3] found 40
functional imaging studies about ToM. Prefrontal re-
gions, especially the medial prefrontal and orbitofrontal
cortices, were associated with ToM in 93 % of studies.
The anterior cingulate cortex, superior temporal sulcus
(STS) and temporoparietal junction (TPJ) were involved
in 50–60 % of studies. Poletti et al. [4] proposed a model
for ToM processing with common brain areas (precu-
neus, TPJ and STS) for both the affective and cognitive
components of ToM, as well as for specific areas for
each component. Indeed, the ventromedial prefrontal re-
gion would be preferentially involved in affective ToM
[5], while cognitive ToM would be supported by the
dorsolateral prefrontal cortex [6].
The first publications about ToM reported studies on
patients with autism [7] or schizophrenia [8]. In the
2000s, researchers began to assess ToM in neurological
diseases. One of the first of these studies was by Gregory
et al. [9], who showed ToM impairments in patients
with frontotemporal lobe degeneration. These results
were confirmed in other studies (for review, see [10])
that revealed a substantial, early and global deficit of
both components of ToM in this disease. However, this
is not the case in other neurodegenerative diseases, such
as Alzheimer’s disease (AD) and Parkinson’s disease
(PD). In AD, patients are relatively preserved from ToM
impairment at the beginning of the disease, with subtle
difficulties in high-demand cognitive tests [9, 11, 12]. In
PD, it has been reported that patients develop ToM im-
pairments as the disease progresses, particularly involv-
ing the cognitive component [13–15]. Studies on ToM
have been carried out in many other neurological dis-
eases, including Huntington’s disease [16], amyotrophic
lateral sclerosis [17], corticobasal degeneration [18], se-
mantic dementia [19], progressive supranuclear palsy
[20] and multiple sclerosis [21], but no studies have
assessed ToM in dementia with Lewy bodies (DLB).
DLB is the second most common cause of neurodegen-
erative dementia after AD in people aged over 65 years.
DLB is characterized by intra-neuronal inclusions of α-
synuclein, called Lewy bodies. In series of demented pa-
tients, 15–25 % of patients had pathological lesions of
DLB [22]. Patients with DLB sometimes have social be-
havioural disorders, even in the first stage of the disease
[23]. We hypothesised that these disorders are caused by
ToM impairments. The only publication evoking ToM
in DLB is Modinos et al.’s study [24]. They assessed
ToM in five patients with different types of dementia:
mild cognitive impairment, AD, frontotemporal demen-
tia, vascular dementia and DLB. Their patient with DLB
performed worse than the patient with AD and the one
with mild cognitive impairment but better than the pa-
tient with frontotemporal dementia. This result is in line
with our hypothesis, but a prospective study was needed
to confirm this case report.
The aim of our study was to assess affective and cogni-
tive ToM in patients with DLB in the early stage of the
disease, and to search for the neural correlates of these
deficits. We hypothesised first that patients with DLB
would have cognitive and affective ToM impairments
and second that any such cognitive deficit would be cor-
related predominantly to atrophy in the prefrontal cor-
tex and the TPJ.
Methods
Selection of participants
We conducted a prospective, single-centre, multi-site
study between June 2012 and January 2015 with patients
with probable DLB (DLB group) or probable AD (AD
group), in all cases in the early stage of the disease, and
with healthy elderly control subjects (HC group). Pa-
tients were included by six neurologists and geriatri-
cians, experts in dementia, at the Memory Resource and
Research Centre of the University Hospital of Strasbourg
in France. Healthy elderly subjects were recruited by
means of an advertisement for volunteers in a local
newspaper. The study was approved by the local ethics
committee (Comité de Protection des Personnes Est IV,
Strasbourg, France), and all participants gave their writ-
ten informed consent.
Inclusion criteria for patients with DLB and patients
with AD were as follows: age 45 years or older, presence
of probable DLB as defined by McKeith’s criteria revised
in 2005 [25] and the Diagnostic and Statistical Manual
of Mental Disorders, Fifth Edition [26], or probable AD
as defined by Dubois’s criteria [27] in the early stage of
the disease, as defined in both cases by impairment ac-
cording to results of at least two neuropsychological
tests and a Mini Mental State Examination (MMSE)
score higher than 20. Patients were excluded in the case
of diagnostic doubt, association of AD and DLB, other
central neurological or psychiatric disease, visual or
hearing disorders or difficulty in speaking French.
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Inclusion criteria for healthy subjects were age be-
tween 55 and 90 years, absence of neurological or psy-
chiatric history, a normal neurological examination and
absence of impairment on neuropsychological tests (ex-
cluding ToM tests).
First, the three groups were examined by clinicians
with expertise in dementia in order to perform a
complete anamnesis and medical examination. Using the
Unified Parkinson’s Disease Rating Scale III score [28],
akinesia, rigidity and tremor at rest were rated from 0
(no symptoms) to 4 (serious impairment). Fluctuations
were assessed with the Mayo Clinic Fluctuation Scale
[29] and the Clinician Assessment of Fluctuation [30].
The medical check-up was completed with cerebral
magnetic resonance imaging (MRI) for the three
groups and lumbar puncture with AD biomarkers
(tau, phosphorylated tau and amyloid-β42) for the
DLB and AD groups. DaTscan (GE Healthcare/Medi-
Physics, Arlington Heights, IL, USA), a radiopharmaceu-
tical agent used in single-photon emission computed
tomography (SPECT) for striatal dopamine transporter
visualization of the brain, was employed if the extrapyram-
idal syndrome was unclear.
Second, cognitive functions were evaluated using the
following tests: MMSE [31] for general cognitive func-
tion; the French version of the Free and Cued Selective
Reminding Test (FCSRT) [32, 33], the 48-item Delayed
Matching to Sample (DMS48) test [34] and the digit
span test for memory function; the 80-item Dénomin-
ation Orale (DO80; an oral naming test) [35] for lan-
guage; the Frontal Assessment Battery (FAB) [36], the
Trail Making Test (TMT) A and B [37], the Digit
Symbol Substitution Test (DSST) [38] and ‘formal and
semantic lexical evocation’ [39] for executive function;
the praxis set of Mahieux [40] and the Rey-Osterrieth
complex figure test [41] for praxis; and number local-
isation and cube analysis of the Visual Object and
Space Perception (VOSP) battery [42] for visuoper-
ceptive functions.
ToM tasks
ToM was assessed by have participants perform three
tasks: the FPR test, the RME test and Ekman’s Facial
Emotion Recognition test.
The FPR test [43] is frequently used to assess cognitive
and affective components of ToM. We used the short-
ened version, in which ten stories are read to partici-
pants: five containing a social faux pas (faux pas stories)
and five control stories without a social faux pas (control
stories). For each of the faux pas stories, participants
were asked the following questions (faux pas questions):
(1) ‘Did anyone say something he or she shouldn’t have
said’? (2) ‘Who said something he or she shouldn’t have
said’? (3) ‘Why shouldn’t he or she have said it’? (4)
‘Why do you think he or she said it’? (5) ‘Did X know
that Y…’? (6) ‘How did X feel’? One point was given for
each faux pas question (i.e., a total possible score of 30
points for the 5 faux pas stories). Two points were given
for correct rejection of control stories (i.e., a total pos-
sible score of ten points for the five control stories). For
each story (faux pas and control stories), two control
questions were asked to check that participants under-
stood the details of the story. One point was given for
each control question (i.e., a total possible score of 20
points for the 10 stories). In our results, the scores for
the following questions were also considered separately:
questions 3 and 4, assessing the participant’s compre-
hension of the faux pas; question 5, assessing the partici-
pant’s comprehension of the character’s intention; and
question 6, assessing the participant’s capacity for attrib-
uting emotions to the victim of the faux pas. This last
question is used to evaluate affective ToM, and the other
questions are used to evaluate cognitive ToM.
The French version of the RME test [44] is used to as-
sess affective ToM on the basis of comprehension of
complex mental states. Thirty-six photographs of the eye
region of the faces of actors and actresses were pre-
sented to participants. Participants were required to
choose which of four adjectives best described the men-
tal state. A glossary with all of the proposed adjectives
could be used during the assessment.
Ekman’s Facial Emotion Recognition test [45] is also
used to assess affective ToM, but with a lower level of
difficulty than the RME test. Thirty-five photographs of
faces were presented to participants. The participants
were asked to choose which of the following emotions
corresponded to the facial expression: ‘happiness’ , ‘fear’ ,
‘anger’ , ‘disgust’ , ‘surprise’ , ‘sadness’ or ‘neutral’.
Finally, we calculated the global score for the mini-
Social cognition and Emotional Assessment (mini-SEA)
battery [46] using the FPR test score and Ekman’s Facial
Emotion Recognition test score.
For each test, we compared the patients’ results with
standardized scores and classified them into successful
or failed groups. We used the standardized scores of the
mini-SEA [46] for the FPR test and Ekman’s Facial
Emotion Recognition test, and Baron-Cohen’s standar-
dised scores [44] were used for the RME test. The score
was considered pathological for a z-score less than −1.6.
Scanning protocol
Twenty-four patients with DLB, nine patients with AD
and fifteen healthy control subjects underwent cerebral
MRI in a 3-T MAGNETOM Verio scanner (Siemens
Healthcare, Erlangen, Germany). T1-weighted spin echo
sequences were collected using the following parameters:
repetition time = 1900 ms, echo time = 2.53 ms, in-
version time = 900 ms, field of view = 192 mm and
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slice thickness = 1 mm. The voxel size was 1 mm ×
1 mm × 1 mm.
Data processing
For image processing, we used SPM12 software (Statis-
tical Parametric Mapping; Wellcome Trust Centre for
Neuroimaging, London, UK; http://www.fil.ion.ucl.ac.uk/
spm) running on MATLAB R2010a (MathWorks, Na-
tick, MA, USA). Images of each patient were spatially
normalised to the Montreal Neurological Institute space.
T1-weighted images were segmented into grey matter,
white matter, cerebrospinal fluid (CSF), bone, fat and air.
Grey matter images were modulated and smoothed with
a Gaussian kernel of 8 mm.
Voxel-based morphometry
Atrophy of grey matter was analysed using voxel-based
morphometry (VBM) in SPM12 in an exploratory
whole-brain analysis. First, two-sample one-tailed t
tests between the HC group and the DLB group and
between the HC group and the AD group were per-
formed in order to confirm that brain atrophy in the
DLB group and the AD group was congruent with
previous reports in the literature. Second, we per-
formed an analysis in the DLB group to search for
neural correlates of ToM impairment. For this pur-
pose, we performed a one-sample, one-tailed t test to
investigate the correlation between each ToM score
and grey matter volume, and a two-sample, one-
tailed t test to compare patients with DLB who were
impaired with those who were non-impaired for each
ToM test. Age and global grey matter volume were
considered as nuisance covariates for all of the ana-
lyses. Statistical maps were thresholded at P < 0.001,
uncorrected, and with a minimum cluster size of
25 voxels. Statistical maps were analysed with xjView
(http://www.alivelearn.net/xjview8/), which enabled us
to identify the brain regions that were associated
with the detected clusters.
Statistical analysis
IBM SPSS version 21.0 software (IBM, Armonk, NY,
USA) was used for further statistical evaluation as
required. Where appropriate, differences in demo-
graphic and clinical data were assessed using paramet-
ric (analysis of variance, t tests) and non-parametric
tests (Kruskal-Wallis test) with post hoc analysis. For
categorical measures, χ2 tests were applied. Correla-
tions between clinical data, neuropsychological tests
and ToM tests were assessed using Spearman’s test.




Ninety-six participants were recruited to perform ToM
tasks. Twenty-eight patients were excluded for the fol-
lowing reasons: too severe stage of the disease (n = 9),
presence of another neurological or psychiatric disease
(n = 10), possible DLB or AD but without criteria for
probable DLB or AD (n = 5), association of DLB and AD
(n = 1), subjective memory complaint without objective
impairments on neurological tests (n = 2) and insuffi-
cient knowledge of French (n = 1). Four healthy subjects
were excluded because of psychiatric disorder (n = 1), in-
complete file (n = 1), presence of hallucinations (n = 1)
and presence of parkinsonism (n = 1). Ultimately, 64 par-
ticipants were included in the study: 33 patients in the
DLB group, 15 patients in the AD group and 16 elderly
healthy subjects in the HC group.
There were no significant differences between the
DLB, AD and HC groups for age, sex, handedness or
level of education (all P > 0.05). The three groups’ demo-
graphic and clinical characteristics are presented in
Table 1. There were no significant differences between
the DLB and AD groups for disease duration, mean
MMSE score or mean instrumental activities of daily liv-
ing (IADL) score. Eighty-two percent of patients with
DLB and 80 % of patients with AD had a lumbar
puncture. AD biomarkers were always negative in the
patients with DLB and always positive in the patients
with AD. Fourteen patients with DLB underwent
DatScan SPECT, and dopaminergic denervation was
found in 64 % of cases.
The results of the general neuropsychological tests are
presented in Table 2. Patients with DLB were in a stage
of mild cognitive impairment, but they performed poorly
compared with the HC group in the majority of tasks.
The mean MMSE scores were 27.2 for patients with
DLB, 27 for patients with AD and 29.3 for HC. Patients
with DLB had significantly more memory impairments
than HC (FCSRT and DMS48) and more difficulty with
executive, speed processing, praxis and attentional tasks
(TMT A and B, DSST, digit span and lexical evocation).
The DLB and AD groups performed similarly on all
these tests except the FCSRT, on which patients with
AD performed worse than patients with DLB, and also
abstract praxis, on which the DLB group performed
worse than the AD group.
ToM tasks
Table 3 displays data for ToM tasks.
Ekman’s Facial Emotion Recognition test
We found no statistical difference between the three
groups for Ekman’s Facial Emotion Recognition test. A
similar percentage of subjects failed this test in the two
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groups of patients (28.6 % in the DLB group versus
23.1 % in the AD group and 12.5 % in HC subjects; P =
0.66). Mean scores were similar between the three
groups (27.1 in the DLB group versus 26.6 in the AD
group and 28.6 in the HC group; P = 0.303). All the sub-
jects had difficulty in identifying fear, anger and sadness,
in the same proportions (P > 0.05). The only difference
between the three groups concerned the recognition of
surprise (4.1 in the DLB group and the AD group versus
4.9 in the HC group, P = 0.001).
Reading the Mind in the Eyes test
We found a significant difference between patients
with DLB and the HC group for the mean score on
this test (20.6 in the DLB group versus 23.9 in the HC
group; P = 0.015). Forty-eight percent of patients with
DLB failed this test versus 14 % of the HC group.
Thirty-three percent of patients with AD failed this
test, but there were no significant differences between
the AD group and the HC group or between the AD
group and the DLB group.
Faux Pas Recognition test
According to the mini-SEA standardized score for the
FPR test, 42 % of patients with DLB and 43 % of patients
with AD failed this test versus 12 % of HC (P = 0.071).
Patients with DLB performed significantly worse than
HC for faux pas stories (P = 0.033). There were no
Table 1 Clinical and demographic features of patients with dementia with Lewy bodies, patients with Alzheimer’s disease and
healthy elderly control subjects
HC (n = 16) DLB (n = 33) AD (n = 15) Test statistic, P value Post hoc analysis
Sex, M/F 7/9 16/17 8/7 χ2 = 0.097, P = 0.952
Age, yra 68.3 (10.5) 68 (8.4) 70.9 (11.1) F = 0.491, P = 0.614
Handedness, R/L 15/1 30/3 14/1 χ2 = 0.156, P = 0.925
Education, yra 11.9 (3.2) 12.4 (3.2) 13.5 (3.6) F = 0.882, P = 0.419
Disease duration, yra 4.6 (4.2) 3.6 (1.8) F = 0.715, P = 0.402
MMSEa 29.3 (0.9) 27.2 (1.8) 27 (2.6) H = 17.833, P < 0.000 HC > DLB and AD
IADL on scale of 8a 7.8 (0.4) 7.1 (1.3) 7.6 (0.8) H = 3.671, P = 0.160
Hallucinations 0 % 66.6 % 0 % χ2 = 31.492, P < 0.000
Fluctuations
Mayo Clinic Fluctuation Scale 37.5 % 93.9 % 26.7 % χ2 = 26.810, P < 0.000
Clinician Assessment of Fluctuation 0.56 (2.25) 3.78 (3.1) 0.38 (1) H = 22.050, P < 0.000 DLB > HC and AD
Parkinsonism
Akinesia (0/1/2/3/4) 16/0/0/0/0 11/18/4/0/0 15/1/0/0/0 H = 27.189, P < 0.000 DLB > HC and AD
Rigidity (0/1/2/3/4) 16/0/0/0/0 4/25/3/1/0 10/5/0/0/0 H = 35.112, P < 0.000 DLB > HC and AD
Tremor at rest (0/1/2/3/4) 16/0/0/0/0 20/12/0/0/0 13/2/0/0/0 H = 9.031, P = 0.011 DLB > HC
Treatments
Cholinesterase inhibitor 0 % 28.1 % 41.7 % χ2 = 7.535 P = 0.023
Neuroleptics 0 % 6.3 % 0 % χ2 = 1.810, P = 0.404
L-dopa or dopaminergic agonists 6.3 %b 43.8 % 0 % χ2 = 11.611, P = 0.003
Cerebrospinal fluid
Normal/abnormal 27/0 0/12 χ2 = 40, P < 0.000
Aβ42a 943.1 (334.5) 533.3 (306.9) F = 12.369, P = 0.001 DLB > AD
Taua 303.1 (110.1) 643.1 (305.7) F = 27.135, P < 0.000 AD > DLB
p-Taua 46.3 (14.3) 86.7 (26.6) F = 38.712, P < 0.000 AD > DLB
IATIa 1.7 (0.5) 0.6 (0.3) F = 35.606, P < 0.000 DLB > AD
Hippocampi atrophy
Right (0/1/2/3/4) 4/9/2/0/0 11/10/5/1/0 0/3/6/0/0 H = 8.030, P = 0.018 AD > HC and DLB
Left (0/1/2/3/4) 6/7/2/0/0 13/8/5/1/0 0/5/3/1/0 H = 6.590, P = 0.037 AD > DLB
Aβ42 amyloid-β42 AD Alzheimer’s disease, HC healthy control subjects, DLB dementia with Lewy bodies, MMSE Mini Mental State Examination, IADL Instrumental
Activities of Daily Living, IATI INNOTEST Amyloid Tau Index (Fujirebio, Ghent, Belgium), F analysis of variance, H Kruskal-Wallis test, p-tau phosphorylated tau
aMean (standard deviation)
bOne healthy control subject had dopaminergic agonist treatment for restless legs syndrome
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significant differences between the AD group and
the HC group or between the AD group and the
DLB group. No significant difference was observed
between the three groups for the number of correct
hits (P = 0.271), question 3 (P = 0.415) and question
4 (P = 0.213), intentionality (P = 0.271), or emotional
attribution (P = 0.064). Patients with DLB performed
worse than the other groups for this last question,
but the difference was not significant. Patients with
DLB and patients with AD correctly rejected the
control stories. The comprehension of stories was
preserved, with high scores for control questions in
the three groups (P = 0.053).
Mini-Social cognition and Emotional Assessment score
A significant difference was found between the DLB
group and the HC group for the global mini-SEA score
(P = 0.008) (Table 3). This score is based on Ekman’s Fa-
cial Emotion Recognition test score and the composite
score of the FPR test. Patients with AD had a lower
score than HC, but the difference was not significant.
There was no significant difference between the DLB
group and the AD group.
We found a significant correlation between education
level and scores on Ekman’s Facial Emotion Recognition
test, the RME test and the FPR test (all P < 0.05). The
score on the RME test was correlated with executive
Table 2 Neuropsychological features of patients with dementia with Lewy bodies, patients with Alzheimer’s disease and healthy
elderly control subjects
HC (n = 16) DLB (n = 33) AD (n = 15) Test statistic, P value Post hoc analysis
FAB on scale of 18a 17.3 (1.2) 15.3 (2.2) 15 (3.2) H = 13.343, P = 0.001 HC > DLB and AD
FCSRT
IR on scale of 16a 15.8 (0.4) 14.8 (1.4) 13.5 (2) H = 18.429, P < 0.000 HC > DLB and AD, DLB > AD
FR on scale of 48a 31.3 (3.9) 22.6 (7.9) 9.4 (7) H = 36.616, P < 0.000 HC > DLB and AD, DLB > AD
TR on scale of 48a 47.3 (0.9) 43 (6.8) 25.5 (12.3) H = 32.488, P < 0.000 HC > DLB and AD, DLB > AD
CFR on scale of 16a 12.6 (1.7) 8.5 (3.8) 3.3 (4) H = 26.461, P < 0.000 HC > DLB and AD, DLB > AD
CTR on scale of 16a 15.9 (0.3) 14.8 (2) 8.8 (4.9) H = 26.548, P < 0.000 HC and DLB > AD
DMS48
Set 1,a % 99 (2) 93 (6) 88 (11) H = 13.752, P = 0.001 HC > DLB and AD
Set 2,a % 99 (1) 93 (7) 83 (10) H = 19.771, P < 0.000 HC > DLB and AD
Rey-Osterrieth complex figure testa 34.5 (1.6) 29.6 (7.9) 31.7 (4.2) H = 6.088, P = 0.048 HC > DLB
VOSP
Number localisationa 10.1 (2.7) 8.2 (2.2) 8.3 (2.3) H = 5.526, P = 0.063
Cube analysisa 10 (2.1) 9 (1.5) 7.9 (3.4) H = 2.677, P = 0.262
TMT Aa 42.7 (13.9) 64.3 (27.7) 53.7 (15.3) H = 9.09, P = 0.011 DLB > HC
TMT Ba 97.9 (34.1) 164.2 (89.8) 149.5 (73.5) H = 8.994, P = 0.011 DLB > HC
DSST on scale of 19a 11.4 (2.3) 7.7 (2.3) 10.3 (3) H = 17.972, P < 0.000 HC > DLB
Digit span
Directa 8.8 (2.2) 6.8 (1.9) 7.7 (2.6) H = 4.499, P = 0.105
Indirecta 5.8 (1.8) 4.4 (1.5) 4.5 (1.4) H = 7.781, P = 0.02 HC > DLB
Lexical evocation
Formala 24.6 (8.6) 16 (7.7) 22.7 (7.1) H = 11.814, P = 0.003 HC > DLB
Semantica 37 (7.9) 23.7 (7.5) 21.6 (9.5) H = 23.494, P < 0.000 HC > DLB and AD
DO80a 79.6 (0.6) 77.1 (3.5) 71.2 (20.3) H = 8.655, P = 0.013 HC > DLB and AD
Praxis
Symbolica 4.9 (0.5) 4.7 (0.5) 5.4 (1.6) H = 4.104, P = 0.128
Actiona 9.9 (0.3) 9 (1.3) 9.4 (0.8) H = 6.761, P = 0.034 HC > DLB
Abstracta 7.9 (0.5) 6.6 (1.7) 7.9 (0.3) H = 14.780, P = 0.001 HC and AD > DLB
AD Alzheimer’s disease, CFR cued free recall, CTR cued total recall, DMS Delayed Matching to Sample, DLB dementia with Lewy bodies, DO Dénomination
Orale (an oral naming test), DSST Digit Symbol Substitution Test, FAB Frontal Assessment Battery, FCSRT Free and Cued Selective Reminding Test, FR free
recall, HC healthy control subjects, IR immediate recall, TMT Trail Making Test, TR total recall, VOSP Visual Object and Space Perception, H Kruskal-Wallis test
aMean (standard deviation)
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function (FAB, TMT B and semantic lexical evocation),
the Rey-Osterrieth complex figure test score and the
IADL score. We did not find any correlations between
the RME test, the FPR test, the mini-SEA score and ei-
ther age or disease duration. Ekman’s Facial Emotion
Recognition test and FPR test scores were not correlated
with any of the neuropsychological tests (Table 4).
VBM analysis
Comparison of atrophy between patients with DLB, patients
with AD and HC group
VBM analysis revealed some regions of atrophy in the
DLB group, compared with HC, in the frontal lobe
(medial, middle and inferior frontal gyri; anterior cingu-
late cortex; and orbital gyrus), the temporal lobe (bilat-
eral superior and left inferior temporal gyri) and the
bilateral insula (P < 0.001, uncorrected, minimum cluster
size of 25 voxels) (Fig. 1 and Additional files 1 and 2).
Patients with AD were particularly atrophied in the bi-
lateral medial temporal lobe (fusiform and parahippo-
campal gyri, hippocampus) compared with HC (P < 0.05,
family-wise error–corrected, minimum cluster size of
25 voxels). They also presented more atrophy than HC
in the frontal lobe (superior, middle and medial frontal
gyri and cingulate gyrus), the right superior temporal
gyrus and the right insula (P < 0.001, uncorrected, mini-
mum cluster size of 25 voxels) (Fig. 2 and Additional
files 1 and 2).
Compared with the DLB group, the AD group was more
atrophied in the left middle frontal gyrus, the bilateral par-
ietal lobe (superior and inferior parietal gyrus, precuneus),
the right cuneus and the left lingual gyrus, and especially
in the bilateral medial temporal lobe (fusiform gyrus,
amygdala, hippocampus and parahippocampal gyrus).
Compared with the AD group, the DLB group was more
atrophied in the left cingulate gyrus and the right middle
Table 3 Theory of mind tests of patients with dementia with Lewy bodies, patients with Alzheimer’s disease and healthy elderly
control subjects
HC (n = 16) DLB (n = 33) AD (n = 15) Test statistic, P value Post hoc analysis
Ekman’s Facial Emotion Recognition test
Impaired subjects 12.5 % 28.6 % 23.1 % χ2 = 0.830, P = 0.660
Total score on scale of 35 28.6 (3.2) 27.1 (3.3) 26.6 (2.8) H = 2.39, P = 0.303
Happiness on scale of 5 5 (0) 4.8 (0.4) 4.8 (0.4) H = 3.244, P = 0.197
Fear on scale of 5 2.1 (1.3) 2.1 (1.3) 1.9 (1.6) H = 0.295, P = 0.863
Disgust on scale of 5 4.3 (0.8) 4 (1) 4.3 (1.3) H = 3.337, P = 0.189
Anger on scale of 5) 3.6 (1.3) 3.9 (1.1) 3.6 (1.3) H = 0.344, P = 0.842
Surprise on scale of 5 4.9 (0.3) 4.1 (0.7) 4.1 (0.6) H = 15.573, P = 0.001 HC > DLB and AD
Sadness on scale of 5 3.7 (1.3) 3.8 (1.1) 3.5 (1.4) H = 0.174, P = 0.917
Neutral on scale of 5 4.9 (0.3) 4.5 (1) 4.5 (0.7) H = 3.774, P = 0.151
Reading the Mind in the Eyes test
Impaired subjects 14.3 % 48.4 % 33.3 % χ2 = 4.066, P = 0.131
Total score on scale of 36 23.9 (2.8) 20.6 (4.2) 21.6 (3.4) H = 8.425, P = 0.015 HC > DLB
Faux Pas Recognition test
Impaired subjects 12.5 % 42.3 % 43.9 % χ2 = 5.301 P = 0.071
Faux pas stories on scale of 30 23.8 (4.2) 19.3 (5.3) 20.6 (6) H = 6.817, P = 0.033 HC > DLB
Corrects hits on scale of 5 4.8 (0.4) 4.3 (1) 4.4 (0.9) H = 2.61, P = 0.271
Question 3, % 84.1 (18.4) 76.4 (25.3) 75.5 (16.3) H = 1.761, P = 0.415
Question 4, % 48.1 (24.3) 35.5 (26.5) 33.6 (26.4) H = 3.091, P = 0.213
Intentionality, % 80.9 (22.2) 82.5 (20.1) 69.2 (28.3) H = 2.611, P = 0.271
Emotional attribution, % 89.1 (15.4) 71.4 (26.4) 83 (17.5) H = 5.493, P = 0.064
Correct rejection on scale of 10 9.6 (1.1) 8.9 (2) 8.7 (2.2) H = 2.04, P = 0.361
CQ on scale of 20 19.9 (0.3) 19.2 (1.7) 19.1 (1) H = 5.868, P = 0.053
Mini-SEA on scale of 30 24.7 (2.4) 21.9 (2.9) 22.7 (2.2) H = 9.682, P = 0.008 HC > DLB
AD Alzheimer’s disease, DLB dementia with Lewy bodies, HC healthy control subjects, CQ control questions, Mini-SEA Social cognition and Emotional Assessment,
H Kruskal-Wallis test
Data are expressed as percentage or mean (standard deviation)
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frontal gyrus (P < 0.001, uncorrected, minimum cluster
size of 25 voxels) (Additional files 1 and 2).
Correlation analysis for Ekman’s Facial Emotion
Recognition test
In the DLB group, impairment on Ekman’s Facial Emotion
Recognition test was correlated with atrophy in the right
middle frontal gyrus (Brodmann’s area [BA] 10) and the
left precuneus (BA 31) (P < 0.001, uncorrected, minimum
cluster size of 25 voxels) (Table 5 and Fig. 3).
Owing to the limited number of MRI images for im-
paired patients with DLB for this test (n = 4), no signifi-
cant results were found in the group analysis comparing
impaired and non-impaired patients in the DLB group.
Correlation analysis and group analysis for the RME test
Impairment on the RME test in the DLB group was
correlated with diminished volume of the right middle
(BA 9) and inferior frontal (BA 10) gyri (P < 0.001, un-
corrected, minimum cluster size of 25 voxels) (Table 5
and Fig. 3).
Group analysis comparing impaired and non-impaired
patients with DLB revealed atrophy in impaired patients
in the bilateral superior and middle frontal gyri (BA 6, 9,
10, 11 and 46), the left orbital gyrus (BA 11), the right
inferior parietal lobule (BA 40) and the right fusiform
gyrus (BA 19) (P < 0.001, uncorrected, minimum cluster
size of 25 voxels) (Table 5 and Fig. 3).
Correlation analysis and group analysis for the FPR test
Impairment on the FPR test in the DLB group was cor-
related with atrophy in the right medial frontal gyrus
Table 4 Spearman’s correlations between clinical and












Age −0.408 −0.351 0.072 −0.026
Education level 0.527a 0.265 0.410a 0.527a
Disease duration −0.125 0.007 0.198 −0.017
IADL 0.433 0.423a 0.198 0.210
MMSE 0.216 0.243 0.226 0.262
FAB 0.365 0.480b 0.193 0.331
Rey-Osterrieth complex
figure test
0.312 0.410a 0.770 0.226
Number localisation 0.358 0.241 0.177 0.324
Cube analysis 0.189 0.213 0.023 0.337
TMT A 0.102 −0.231 −0.220 −0.175
TMT B −0.230 −0.549b −0.024 −0.160
Indirect digit span 0.088 0.140 −0.270 −0.138
Phonemic lexical evocation 0.276 0.287 0.269 0.248
Semantic lexical evocation 0.295 0.403a 0.254 0.198
IADL Instrumental Activities of Daily Living test, FAB Frontal Assessment
Battery, FPR Faux Pas Recognition, MMSE Mini Mental State Examination, RME
Reading the Mind in the Eyes, Mini-SEA mini-Social cognition and Emotional
Assessment, TMT Trail Making Test
aP < 0.05
bP < 0.005
Fig. 1 Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group compared with the healthy control group.
Comparison between the dementia with Lewy bodies group and the healthy control group shows relative grey matter atrophy in frontal,
temporal and insular regions (P < 0.001, uncorrected, minimum cluster size of 25 voxels)
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(BA 10), the right cingulate gyrus (BA 32), the right
supramarginal gyrus (BA 40), the right precuneus (BA 7)
and the left insula (BA 13) (P < 0.001, uncorrected, mini-
mum cluster size of 25 voxels) (Table 5 and Fig. 3).
Group analysis comparing impaired and non-impaired
patients with DLB showed diminished volume in im-
paired patients in frontal regions (superior, medial and
inferior frontal gyri), the left orbital gyrus and the left in-
sula (P < 0.001, uncorrected, minimum cluster size of
25 voxels) (Table 5 and Fig. 3).
Discussion
ToM impairments in dementia with Lewy bodies
This study is the first to assess ToM performance in pa-
tients with DLB. The results confirm the hypothesis of
ToM impairments in patients with DLB, with deficits on
the RME test and on the FPR test. The patients with
DLB in our study were mildly impaired, some with nor-
mal activity of daily living, with a mean MMSE score of
27 and relatively preserved performance on other neuro-
psychological tasks. Thus, ToM seems to be impaired at
the early stage of the DLB.
Patients with DLB had preservation of low-demand
affective ToM tasks such as Ekman’s Facial Emotion
Recognition test but were impaired for high-demand
affective ToM tasks such as the RME test. In Ekman’s
Facial Emotion Recognition test, patients and HC were
similarly impaired in recognizing negative emotions such
as fear, anger, disgust and sadness. In their meta-
analysis, Ruffman et al. [47] showed that older healthy
adults performed worse than young adults in identifying
these negative emotions. Their finding may explain why
all three groups in our study were impaired for the rec-
ognition of negative emotions. On the RME test, nearly
50 % of our patients with DLB failed versus only 15 % of
HC; therefore, the deficit was not due to ageing, and
DLB does indeed seem to cause impairments of high-
demand affective ToM. The difference in score between
the AD group and the HC group was not significant, but
we were not able to show a significant difference be-
tween AD and patients with DLB.
Patients with DLB were also impaired for cognitive
ToM tasks such as the FPR test. Forty-two percent of
the patients with DLB failed on this test. They per-
formed worse than the HC group on faux pas stories,
which reflect the detection and explanation of faux pas.
The score of the AD group was better than that of the
DLB group but lower than that of the HC group, though
neither of these differences reached significance. The
most marked deficiency in the DLB group, compared
with the HC and AD groups, was on the question about
emotional attribution, which assesses the affective com-
ponent of ToM. Impairments on this test were not
caused by an inability to understand the stories as all the
subjects performed well on the control questions.
Thus, both affective and cognitive components were
impaired in DLB, patients having difficulty in inter-
preting the intentions of others, recognising complex
feelings and imagining another’s feelings in a story.
The distinction between these two components of
ToM is interesting because different pathways would
be implicated for each of them [5, 6, 48, 49]. In their
review, Poletti et al. [4] proposed that each neurode-
generative disease would lead to a specific pattern of
Fig. 2 Voxel-based morphometric analysis of global atrophy in the Alzheimer’s disease group compared with the healthy control group.
Comparison between the Alzheimer’s disease group and the healthy control group shows relative grey matter atrophy in medial temporal lobes
and frontal regions (P < 0.001, uncorrected, minimum cluster size of 25 voxels)
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ToM deficits depending on its neuropathological
course and these different patterns could help phy-
sicians to diagnose and distinguish between these
diseases.
The majority of studies that assessed ToM in AD
found impairments on high-cognitive-demanding ToM
tasks whereas low-cognitive-demanding ToM tasks were
preserved [9, 11, 50–54]. As we observed in our study,
Table 5 Voxel-based morphometric analysis for correlations between grey matter volume and theory of mind tasks in the dementia
with Lewy bodies group, and group analysis between impaired and non-impaired patients with dementia with Lewy bodies





sizex axis y axis z axis
Ekman’s Facial Emotion Recognition test
Correlations
Middle frontal gyrus 10 R 36 51 7 8.27 130
Precuneus 31 L −21 −73 25 6.29 37
RME test
Correlations
Middle frontal gyrus 9 R 31 18 36 6.16 99
Inferior frontal gyrus 10 R 39 39 −0 4.41 28
Group analysis
Superior frontal gyrus 9 R 26 35 39 5.30 36
10 L −16 62 15 5.60 177
11 R 22 47 −15 4.33 27
Middle frontal gyrus 6 R 20 5 67 5.18 117
10 R 40 50 6 7.10 283
11 L −24 50 −14 6.11 168
11 R 38 54 −8 5.20 32
46 R 42 29 27 4.73 184
46 L −34 51 7 4.56 47
Orbital gyrus 11 L −3 45 −20 6.46 1396
Inferior parietal lobule 40 R 39 −42 40 4.07 33
Fusiform gyrus 19 R 52 −66 −23 6.84 322
FPR test
Correlations
Medial frontal gyrus 10 R 8 51 10 9.42 129
Cingulate gyrus 32 R 3 29 36 5.33 51
Supramarginal gyrus 40 R 37 −52 25 5.55 28
Precuneus 7 R 9 −76 36 5.16 47
Insula 13 L −38 −7 −8 4.67 42
Group analysis
Superior frontal gyrus 9 L −27 42 33 6 42
Medial frontal gyrus 10 R 8 51 10 4.41 50
Inferior frontal gyrus 46 R 49 42 6 5.64 25
9 L −60 9 28 5.15 42
Orbital gyrus 11 L −3 45 −21 5.88 27
Insula 13 L −38 −6 −9 5.94 41
13 R 40 20 3 5.70 29
BA Brodmann’s area, FPR Faux Pas Recognition, R/L right/left, MNI Montreal Neurological Institute, RME Reading the Mind in the Eyes
P < 0.001, uncorrected, minimum cluster size of 25 voxels
T value: test statistic for t-tests
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Gregory et al. [9] and Narme et al. [55] found lower
scores in patients with AD than in healthy control sub-
jects for the FPR test, but without significant difference.
For the RME test, the data are more heterogeneous.
Gregory et al. [9] found that the performance of patients
with AD was preserved for this test, but Castelli et al.
[53] and Laisney et al. [54] found the opposite. In these
latter two studies, patients with AD were older and had
lower mean scores on the MMSE than those in the study
by Gregory et al. [9], which might explain the different
performance on the RME test. In our study, patients
with AD were more similar to the patients with AD in
Gregory et al.’s study. Overall, the ToM capacities of
patients with AD in the early stage of the disease
seem to be preserved, because they seem to experi-
ence difficulties only with high-demand ToM tasks.
In DLB, ToM deficits seem to be more global and
occur earlier than those reported in AD, but we did
not find any significant differences between these two
groups.
The relationship between ToM and executive function
is a matter of debate. In their review of the literature,
Aboulafia-Brakha et al. [56] showed a congruent associ-
ation between ToM and executive function in 64 % of
studies and incongruent associations in 29 % of studies. In
this review, both FPR and RME tests were strongly corre-
lated with executive function. In our study, we found some
correlations between executive function tests and the RME
test but not with Ekman’s Facial Emotion Recognition test
or the FPR test. In the DLB group, ToM and other cogni-
tive abilities (executive and visuoperceptive functions)
seemed to be relatively independent. Even if ToM can be
linked with executive function in some circumstances, it
seems to be a distinct cognitive function and its exploration
would be useful in clinical practice. However, education
level plays a role in success on ToM tasks.
The social impact of ToM impairments needs to be in-
vestigated further. Few studies have been done on the
clinical implications of ToM. However, Gregory et al. [9]
found a correlation between ToM impairments and the
Fig. 3 Voxel-based morphometric analysis for correlations between grey matter volume and theory of mind tasks in the dementia with Lewy
bodies (DLB) group, and group analysis between impaired and non-impaired patients with DLB. a Ekman’s Facial Emotion Recognition test:
correlations between scores and grey matter atrophy in the DLB group. b Faux Pas Recognition test: correlations between scores and grey matter
atrophy in the DLB group (yellow) and relative atrophy in impaired patients with DLB compared with non-impaired patients (red). c Reading the
Mind in the Eyes test: correlations between scores and grey matter atrophy in the DLB group (yellow) and relative atrophy in impaired patients
with DLB compared with non-impaired patients (red). P < 0.001, uncorrected, minimum cluster size of 25 voxels
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Neuropsychiatric Inventory score, which reflects behav-
ioural disorders. Deficits of ToM in DLB could explain
social interaction disorders such as loss of empathy, ego-
centricity or aggressiveness.
Neural correlates of ToM impairments
Compared with HC, patients with DLB were atrophied
in the frontal and lateral temporal lobes and in the bilat-
eral insula. These results are consistent with previous
data [57–59], particularly for the insula. Indeed, in their
meta-analysis, Zhong et al. [59] showed that the insula is
a core region for atrophy in DLB and could have a role
in autonomic dysfunction. As expected, the patients with
AD in our study were more atrophied in the medial tem-
poral lobes than were the HC and patients with DLB.
These patterns of atrophy demonstrate the homogeneity
of each group.
VBM analysis showed correlations between ToM tasks
and cerebral atrophy in different cerebral regions. Pre-
frontal cortex atrophy was correlated with impairments
on the three ToM tests; specific cerebral regions were
then found for each test. The prefrontal cortex is known
for its role in executive function, such as attention, plan-
ning, decision-making and working memory [60]. This
region is classically associated with ToM [7, 46, 61–63].
In their review, Carrington and Bailey [3] reported an in-
volvement of the medial prefrontal cortex and orbito-
frontal cortex in 93 % of studies and an involvement of
the lateral prefrontal cortex in 35 % of studies. Accord-
ing to lesion and neuroimaging studies, the medial pre-
frontal cortex is implicated in affective ToM [5] while
the lateral prefrontal cortex is implicated in cognitive
ToM [6]. In our study, RME impairments were particu-
larly correlated with atrophy in the orbitofrontal cortex.
This region has often been reported to be involved in
affective ToM [64–66]. Its role in regulation of emotions
is known, and patients with lesions in the orbitofrontal
cortex have social behaviour impairments. Hynes et al.
[64] stated that the orbitofrontal cortex has a role in the
automatic response to a social stimulus, without explicit
judgement about this stimulus, and allows us to adapt our
behaviour. In our study, the FPR test was also correlated
with the medial prefrontal cortex and orbitofrontal cortex.
Even if the FPR test assesses cognitive ToM, some studies
found a link between the FPR test and the medial prefrontal
cortex [48, 67, 68]. Moreover, patients with DLB failed es-
pecially on the last question of the FPR test, concerning
emotional attribution. The atrophy in the medial prefrontal
cortex may explain the difficulty in this empathic question,
and consequently the FPR test impairments.
The inferior frontal cortex is part of the mirror neuron
system and is engaged in both the execution of actions
and the observation of these actions performed by some-
one else. According to the theory of simulation, other
people’s mental states are represented by simulating their
states with resonant states of one’s own [69]. This process
implies mirror neurons and explains the role of the infer-
ior frontal cortex in the RME and FPR tests.
The RME and FPR tests were also correlated with re-
gions of the right TPJ (inferior parietal lobule). This re-
gion is strongly associated with ToM for both the
affective and the cognitive components [3, 70]. Uddin et
al. [71] demonstrated the role of the right TPJ in self–
other distinction. In their study, subjects failed to dis-
criminate self-faces and other familiar faces when repeti-
tive transcranial magnetic stimulation was applied over
this region. Decety and Lamm [72] performed a meta-
analysis to attempt to understand the role of the TPJ in
ToM. In their view, the activation in the TPJ during
ToM tests relies on a ‘lower-level computational mech-
anism involved in generating, testing, and correcting in-
ternal predictions about external sensory events’ and is
not due to a specific role in ToM.
The precuneus, which correlated with FPR and
Ekman’s Facial Emotion Recognition tests in our study,
is a core region of ToM [3, 70]. It is known for its role
in visuospatial perception and episodic memory. Accord-
ing to Cavanna and Trimble [73], the precuneus plays a
role in ToM by using mental imagery to represent the
perspective of another person.
Patients with RME test impairments had relatively
more atrophy in the fusiform gyrus. This region was re-
ported to be related to face and object perception [74].
Furthermore, Gallagher et al. [75] found an association
between the fusiform gyrus and understanding the
meaning of visual jokes. In a similar manner, Baglio et
al. [63] studied performances on the RME test in pa-
tients with amnestic mild cognitive impairment and
found activation of the bilateral fusiform gyrus during
the test. ToM capacities required facial examination me-
diated by the fusiform gyrus.
Patients with FPR test impairments had relatively
more atrophy in the bilateral insula. The role of the in-
sula in emotional response is well known. Bertoux et al.
[46] also found a correlation between the insula and the
FPR test, particularly with the explanation of faux pas.
They supposed that this region was involved in impair-
ment of the last question, about emotional attribution.
This hypothesis is congruent with our findings because
the results for this question were the most impaired in
the DLB group compared with HC.
To summarise, ToM capacities are based not on a sin-
gle cerebral region but on a neuronal network, including
prefrontal regions and the TPJ, precuneus and insula.
Our findings in patients with DLB are consistent with
those reported in healthy subjects, psychiatric patients
and patients with other neurodegenerative cognitive dis-
eases, and they support the existence of such a network.
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Further studies, including functional connectivity (func-
tional and arterial spin labelling MRI) and anatomical
connectivity (diffusion tensor imaging), are now needed
to better characterize this network.
Our study has some limitations. The main limitation is
that patients with DLB were included on the basis of
clinical criteria. Today, the gold standard for the diagno-
sis of DLB is pathology, and there are no biochemical
tests to confirm the diagnosis during the lifetime of the
patient, unlike the CSF biomarkers that exist for AD.
There is therefore a risk of including patients with other
neurodegenerative diseases or with the association of
AD and DLB. However, McKeith’s criteria have very
good specificity (98 %) [76]), and the majority of our
patients had a lumbar puncture, which excluded AD.
Another limitation is that we did not perform specific eval-
uations to determine the social impact of the ToM impair-
ments. It would be interesting in a further study to
investigate this impact on daily living using questionnaires.
Conclusions
In this study, we demonstrate ToM impairments in pa-
tients with DLB. These deficits were present at an early
stage of the disease and affected both the affective and
cognitive components of ToM. Impairments were corre-
lated with atrophy in regions classically involved in ToM
(prefrontal and orbitofrontal cortex, TPJ, precuneus and
insula), which reinforces the hypothesis of a neuronal
network of ToM. Further studies are now needed to
confirm these first results and to better understand the
neural correlates of ToM impairments and their func-
tional and anatomical connectivity.
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